148 related articles for article (PubMed ID: 10322718)
21. Economic models of hepatitis A virus immunization.
O'Connor JB; Imperiale TF; Singer ME
Hepatology; 1999 Jul; 30(1):343-5. PubMed ID: 10428627
[No Abstract] [Full Text] [Related]
22. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults.
O'Connor JB; Imperiale TF; Singer ME
Hepatology; 1999 Oct; 30(4):1077-81. PubMed ID: 10498662
[TBL] [Abstract][Full Text] [Related]
23. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
Myers RP; Gregor JC; Marotta PJ
Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
[TBL] [Abstract][Full Text] [Related]
24. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
25. The prevalence and direct costs of pre-immunization testing for hepatitis A in general practice.
Buckley D; Fahey T; Bevan G
Br J Gen Pract; 1996 Sep; 46(410):541-2. PubMed ID: 8917876
[TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
Jacobs RJ; Koff RS; Meyerhoff AS
Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
[TBL] [Abstract][Full Text] [Related]
28. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis A in Australia in the 1990s: future directions in surveillance and control.
Amin J; Heath T; Morrell S
Commun Dis Intell; 1999 May; 23(5):113-20. PubMed ID: 10429311
[TBL] [Abstract][Full Text] [Related]
31. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
32. Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.
Aggarwal R; Ghoshal UC; Naik SR
Natl Med J India; 2002; 15(6):320-7. PubMed ID: 12540064
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
Chapko MK; Yee HS; Monto A; Dominitz JA
Vaccine; 2010 Feb; 28(7):1726-31. PubMed ID: 20044051
[TBL] [Abstract][Full Text] [Related]
34. Incidence of Hepatitis A in Argentina after vaccination.
Vacchino MN
J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of hepatitis A/B vaccine versus hepatitis B vaccine in public sexually transmitted disease clinics.
Jacobs RJ; Meyerhoff AS
Sex Transm Dis; 2003 Nov; 30(11):859-65. PubMed ID: 14603096
[TBL] [Abstract][Full Text] [Related]
36. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
[TBL] [Abstract][Full Text] [Related]
37. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
Rein DB; Weinbaum CM
Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
[TBL] [Abstract][Full Text] [Related]
39. [The use of decision making analysis for evaluating hepatitis B inoculation strategy].
Zhuang GH; Xu HW
Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):69-73. PubMed ID: 8354107
[TBL] [Abstract][Full Text] [Related]
40. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Jacobs RJ; Rosenthal P; Meyerhoff AS
Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
